ARTICLE | Clinical News
EP-100: Phase II started
May 28, 2012 7:00 AM UTC
Esperance began an open-label, U.S. Phase II trial (ESP2011-002) to compare an IV infusion of EP-100 twice weekly for the first 3 weeks of a 4-week cycle for up to 6 cycles plus weekly IV paclitaxel v...